BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 25582499)

  • 1. Undifferentiated carcinoma of the esophagus: a clinicopathological study of 16 cases.
    Singhi AD; Seethala RR; Nason K; Foxwell TJ; Roche RL; McGrath KM; Levy RM; Luketich JD; Davison JM
    Hum Pathol; 2015 Mar; 46(3):366-75. PubMed ID: 25582499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEGF-C expression in squamous cell carcinoma and adenocarcinoma of the esophagus.
    Möbius C; Freire J; Becker I; Feith M; Brücher BLDM; Hennig M; Siewert JR; Stein HJ
    World J Surg; 2007 Sep; 31(9):1768-1772. PubMed ID: 17354029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The recurrence pattern of esophageal carcinoma after transhiatal resection.
    Hulscher JB; van Sandick JW; Tijssen JG; Obertop H; van Lanschot JJ
    J Am Coll Surg; 2000 Aug; 191(2):143-8. PubMed ID: 10945357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern of lymph node metastases in patients with squamous cell carcinoma of the thoracic esophagus who underwent three-field lymphadenectomy.
    Li H; Zhang Y; Cai H; Xiang J
    Eur Surg Res; 2007; 39(1):1-6. PubMed ID: 17106199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary high-grade neuroendocrine carcinoma of the esophagus: a clinicopathologic and immunohistochemical study of 42 resection cases.
    Huang Q; Wu H; Nie L; Shi J; Lebenthal A; Chen J; Sun Q; Yang J; Huang L; Ye Q
    Am J Surg Pathol; 2013 Apr; 37(4):467-83. PubMed ID: 23426118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basaloid squamous cell carcinoma of the esophagus: diagnosis and prognosis.
    Sarbia M; Verreet P; Bittinger F; Dutkowski P; Heep H; Willers R; Gabbert HE
    Cancer; 1997 May; 79(10):1871-8. PubMed ID: 9149011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A strategy for supraclavicular lymph node dissection using recurrent laryngeal nerve lymph node status in thoracic esophageal squamous cell carcinoma.
    Taniyama Y; Nakamura T; Mitamura A; Teshima J; Katsura K; Abe S; Nakano T; Kamei T; Miyata G; Ouchi N
    Ann Thorac Surg; 2013 Jun; 95(6):1930-7. PubMed ID: 23642437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].
    Wang Y; Wang L; Yang Q; Li J; He M; Yao J; Qi Z; Li B; Qiao X
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):48-54. PubMed ID: 26796807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of histologically node-negative esophageal squamous cell carcinoma.
    Tabira Y; Yasunaga M; Sakaguchi T; Yamaguchi Y; Okuma T; Kawasuji M
    World J Surg; 2002 Dec; 26(12):1446-51. PubMed ID: 12297913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can common hepatic artery lymph node dissection be safely omitted in surgery for clinical T1N0 thoracic esophageal squamous cell carcinoma?
    Shim YM; Park JS; Lee M; Kim D; Kim K
    Dis Esophagus; 2013 Apr; 26(3):272-5. PubMed ID: 22642487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms.
    Tafe LJ; Garg K; Chew I; Tornos C; Soslow RA
    Mod Pathol; 2010 Jun; 23(6):781-9. PubMed ID: 20305618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological parameters predicting recurrence of pT1N0 esophageal squamous cell carcinoma.
    Xue LY; Qin XM; Liu Y; Liang J; Lin H; Xue XM; Zou SM; Zhang MY; Zhang BH; Hui ZG; Zhao ZT; Ren LQ; Zhang YM; Liu XY; Yuan YL; Ying JM; Gao SG; Song YM; Wang GQ; Dawsey SM; Lu N
    World J Gastroenterol; 2018 Dec; 24(45):5154-5166. PubMed ID: 30568392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple primary cancers in esophageal squamous cell carcinoma: incidence and implications.
    Poon RT; Law SY; Chu KM; Branicki FJ; Wong J
    Ann Thorac Surg; 1998 Jun; 65(6):1529-34. PubMed ID: 9647053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of PAR-3 protein expression is associated with invasion, lymph node metastasis, and poor survival in esophageal squamous cell carcinoma.
    Kitaichi T; Yasui K; Gen Y; Dohi O; Iwai N; Tomie A; Yamada N; Terasaki K; Umemura A; Nishikawa T; Yamaguchi K; Moriguchi M; Sumida Y; Mitsuyoshi H; Naito Y; Zen Y; Itoh Y
    Hum Pathol; 2017 Apr; 62():134-140. PubMed ID: 28188749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
    Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
    Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologic features of superficial esophageal squamous cell carcinoma with lymph node and distal metastasis.
    Araki K; Ohno S; Egashira A; Saeki H; Kawaguchi H; Sugimachi K
    Cancer; 2002 Jan; 94(2):570-5. PubMed ID: 11900242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The zinc-finger transcription factor SALL4 is frequently expressed in human cancers: association with clinical outcome in squamous cell carcinoma but not in adenocarcinoma of the esophagus.
    Kilic E; Tennstedt P; Högner A; Lebok P; Sauter G; Bokemeyer C; Izbicki JR; Wilczak W
    Virchows Arch; 2016 Apr; 468(4):483-92. PubMed ID: 26818834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMARCB1 (INI-1)-deficient Sinonasal Carcinoma: A Series of 39 Cases Expanding the Morphologic and Clinicopathologic Spectrum of a Recently Described Entity.
    Agaimy A; Hartmann A; Antonescu CR; Chiosea SI; El-Mofty SK; Geddert H; Iro H; Lewis JS; Märkl B; Mills SE; Riener MO; Robertson T; Sandison A; Semrau S; Simpson RH; Stelow E; Westra WH; Bishop JA
    Am J Surg Pathol; 2017 Apr; 41(4):458-471. PubMed ID: 28291122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Significance of Lymphovascular Invasion for Thoracic Esophageal Squamous Cell Carcinoma.
    Wang S; Chen X; Fan J; Lu L
    Ann Surg Oncol; 2016 Nov; 23(12):4101-4109. PubMed ID: 27436201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokeratin 15 is an Effective Indicator for Progression and Malignancy of Esophageal Squamous Cell Carcinomas.
    Shen YH; Xu CP; Shi ZM; Zhang YJ; Qiao YG; Zhao HP
    Asian Pac J Cancer Prev; 2016; 17(9):4217-4222. PubMed ID: 27797221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.